Clinical Trials in Boston

Showing 9901-9920 of 17,836 trials

Ceprotin Treatment Registry

NCT01127529

The overall objective is to collect and assess data on the treatment, safety, and treatment outcomes of subjects prescribed, receiving and participating in the Ceprotin treatment registry.

Protein C Deficiency

Baxalta now part of Shire43 participantsStarted Jun 2010

Phoenix, Arizona, United States • Orange, California, United States • Aurora, Colorado, United States +25 more locations

COMPLETEDNA< 1 mile

A Controlled Trial of Losartan in Posttraumatic Stress Disorder

NCT02709018

This study is being conducted to determine if losartan, an angiotensin receptor blocker (ARB), is safe and effective in the treatment of posttraumatic stress disorder (PTSD) symptoms. The study is also intended to determine if certain genetic markers are useful in predicting PTSD symptom reduction with losartan. Approximately 160 subjects with chronic PTSD ages 18-65 will participate in this study across five sites. Subjects will be assigned by chance to take either flexibly dosed losartan (up to a maximum dosage of 100 mg) or placebo (which resembles the study drug but has no active ingredients), once a day for 10 weeks. Furthermore, it is hypothesized that CC homozygotes for rs4311 SNP in the ACE gene will have a superior response to losartan on PTSD symptoms compared to T carriers.

Posttraumatic Stress Disorder

University of California, San Diego149 participantsStarted Jul 2016

La Jolla, California, United States • Washington D.C., District of Columbia, United States • Bethesda, Maryland, United States +3 more locations

Ceprotin Treatment Registry

A Controlled Trial of Losartan in Posttraumatic Stress Disorder

Find Trials by Condition in Boston

Cognition and the Immunology of Postoperative Outcomes

Computerized Alcohol Screening for Children and Adolescents (cASCA) in Primary Care

CBP501, Cisplatin and Nivolumab in Advanced Refractory Tumors

Algovita Spinal Cord Stimulation System Hi-Fi Study

Decision Aid Feasibility Trial for Families of Critically Ill Stroke Patients

Physical Therapy Components for Maximum TKR Outcome

Remote Brief Intervention and Referrals to Treatment Service for Alcohol

Patient Global Impression Questions for Activity-Induced Symptoms in Participants With PAH

Optimizing PrEP Uptake & Adherence Among Male Sex Workers (MSW) Using a 2-stage Randomization Design

BrUOG 302:BYL719, Capecitabine and Radiation for Rectal Cancer: A Brown University Oncology Research Group Study

A Study to Assess Safety and Efficacy of Risankizumab Using a New Formulation in Participants With Moderate to Severe Plaque Psoriasis

Ibalizumab Plus Optimized Background Regimen in Treatment-Experienced Patients With Multi-Drug Resistant HIV-1

AMPLEX Ankle Fusion and Hindfoot

Trinity™ BIOLOX Delta™ CoC THR Multi-center Study

Preliminary Study of Piclozotan in Patients With Motor Complications Associated With Parkinson's Disease

Mortality Reduction After Oral Azithromycin: Morbidity Study

Study of Recombinant Factor IX Product, IB1001, in Previously Treated Pediatric Subjects With Hemophilia B

A Study to Assess the Safety of Experimental Medication BMS986165 in Participants With Normal Kidney Function and Participants With Mild to End-Stage Kidney Disease.